On February 1, 2024, Fushine Pharmaceutical (300497.SZ) announced on the Chaohu Information Network about the "Announcement on the Plan of Controlling Shareholders, Actual Controllers, Chairmen and Vice Chairmen of the Board of Directors, and Senior Management Personnel to Increase Their Holdings of the Company's Shares." Based on their recognition of the company's inherent value and their firm confidence in its future sustained and stable development, as well as their commitment to safeguarding the interests of shareholders and enhancing investor confidence, Mr. Zhang Xiangming, Vice General Manager, Mr. Wei Haipeng, Vice General Manager, and Ms. Peng Yun, Vice General Manager and Secretary to the Board of Directors, plan to increase their holdings of the company's shares through centralized bidding or other means permitted by laws and regulations within six months from the date of the announcement, with an increase amount of no less than 300,000 yuan and no more than 600,000 yuan. Recently, the company received a notice from Mr. Zhang Xiangming, Vice General Manager, Mr. Wei Haipeng, Vice General Manager, and Ms. Peng Yun, Vice General Manager and Secretary to the Board of Directors, announcing the completion of their shareholding increases.